| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| B4E0L2 | cDNA FLJ56706, highly similar to Bcl-2 homologous antagonist/killer; | NULL | NULL | 141 | human |
| B4DUF2 | cDNA FLJ50227, moderately similar to Complement decay-accelerating factor; | NULL | NULL | 480 | human |
| B4XAM4 | MHC class I; Fragment; | HLA-A; | NULL | 91 | human |
| B4DIE0 | cDNA FLJ57729, moderately similar to Probable low-affinity copper uptake protein 2; | NULL | NULL | 135 | human |
| A0A087WTA0 | Ubiquitin carboxyl-terminal hydrolase 17-like protein 11; | USP17L11; | NULL | 558 | human |
| B5A241 | CREBBP; Fragment; | CREBBP; | NULL | 52 | human |
| A0A075B6H0 | Receptor-type tyrosine-protein phosphatase T; | PTPRT; | NULL | 1460 | human |
| B5ASL0 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| B4DRS8 | cDNA FLJ54753, highly similar to Homo sapiens guanylate binding protein family, member 6 (GBP6), mRNA; | NULL | NULL | 489 | human |
| B4DTS5 | cDNA FLJ58882, highly similar to 26S proteasome non-ATPase regulatory subunit 11; | NULL | NULL | 314 | human |
| B7SEZ8 | Dentin sialophosphoprotein; Fragment; | DSPP; | NULL | 384 | human |
| B7Z4V5 | cDNA FLJ50590, highly similar to Ser/Thr-rich protein T10 in DGCR region; | NULL | NP_690870.3; | 252 | human |
| A0A087WY40 | LIM/homeobox protein Lhx1; Fragment; | LHX1; | NULL | 141 | human |
| B4E226 | cDNA FLJ57287; | NULL | NULL | 587 | human |
| B4E0X6 | Proteasome subunit alpha type; EC 3.4.25.1; | NULL | NP_001137409.1; | 130 | human |
| B7Z1H0 | cDNA FLJ53971; | NULL | NP_001274442.1; | 449 | human |
| B7Z1X3 | cDNA FLJ51714, highly similar to Growth-arrest-specific protein 8; | NULL | NULL | 382 | human |
| B7Z6Z7 | cDNA FLJ57209, highly similar to Ankyrin repeat domain-containing protein 44; | NULL | NP_710181.2; | 507 | human |
| B7Z555 | cDNA FLJ55311, highly similar to Complement component C8 beta chain; | NULL | NP_001265472.1; | 539 | human |
| B7Z5M1 | cDNA FLJ50625, highly similar to Importin beta-1 subunit; | NULL | NULL | 660 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |